CABALETTA BIO, INC. Increase (Decrease) in Accounts Payable
CABALETTA BIO, INC. (CABA) reported Increase (Decrease) in Accounts Payable of -$1.18 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13
- CABALETTA BIO, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$908.00K, a 252.61% decline year-over-year.
- CABALETTA BIO, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$269.00K, a 116.91% decline year-over-year.
- CABALETTA BIO, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.71M, a 163.12% decline year-over-year.
- CABALETTA BIO, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.07M.
- CABALETTA BIO, INC. increase (decrease) in accounts payable for fiscal 2025 was $1.55M, a 53.31% increase from fiscal 2024.
- CABALETTA BIO, INC. increase (decrease) in accounts payable for fiscal 2024 was $1.01M, a 39.64% decline from fiscal 2023.
- CABALETTA BIO, INC. increase (decrease) in accounts payable for fiscal 2023 was $1.68M.
- CABALETTA BIO, INC. increase (decrease) in accounts payable for fiscal 2022 was -$28.00K, a 102.87% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$908.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.18M 10-Q · filed 2026-08-13 | -$2.88M derived: sum of 3 quarters · filed 2026-08-13 | -$1.81M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$269.00K 10-Q · filed 2026-05-14 | -$1.98M derived: sum of 2 quarters · filed 2026-05-14 | -$905.00K derived: sum of 3 quarters · filed 2026-05-14 | -$310.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$636.00K derived: sum of 2 quarters · filed 2026-03-23 | -$41.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.55M 10-K · filed 2026-03-23 |
| 2025-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.67M derived: sum of 2 quarters · filed 2026-08-13 | $3.26M 10-Q · filed 2025-11-10 | $5.96M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $595.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.19M 10-Q · filed 2026-08-13 | $4.89M derived: sum of 3 quarters · filed 2026-08-13 | $2.88M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.59M 10-Q · filed 2026-05-14 | $4.29M derived: sum of 2 quarters · filed 2026-05-14 | $2.29M derived: sum of 3 quarters · filed 2026-05-14 | $947.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $694.00K derived: sum of 2 quarters · filed 2026-03-23 | -$644.00K derived: sum of 3 quarters · filed 2026-03-23 | $1.01M 10-K · filed 2026-03-23 |
| 2024-09-30 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.35M derived: sum of 2 quarters · filed 2025-11-10 | -$1.69M 10-Q · filed 2025-11-10 | -$1.17M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $317.00K 10-Q · filed 2025-08-07 | $835.00K derived: sum of 3 quarters · filed 2025-08-07 | $2.14M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.66M 10-Q · filed 2025-05-15 | $2.17M derived: sum of 2 quarters · filed 2025-05-15 | $3.48M derived: sum of 3 quarters · filed 2025-05-15 | $1.61M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.82M derived: sum of 2 quarters · filed 2025-03-31 | -$49.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.68M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$567.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.16M 10-Q · filed 2024-11-14 | $2.18M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$145.00K 10-Q · filed 2024-08-08 | $882.00K derived: sum of 3 quarters · filed 2024-08-08 | -$11.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.72M 10-Q · filed 2024-05-15 | $2.75M derived: sum of 2 quarters · filed 2024-05-15 | $1.86M derived: sum of 3 quarters · filed 2024-05-15 | -$16.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $134.00K derived: sum of 2 quarters · filed 2024-03-21 | -$1.74M derived: sum of 3 quarters · filed 2024-03-21 | -$28.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | -$893.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.77M derived: sum of 2 quarters · filed 2023-11-09 | -$1.05M 10-Q · filed 2023-11-09 | -$489.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$162.00K 10-Q · filed 2023-08-10 | $404.00K derived: sum of 3 quarters · filed 2023-08-10 | $183.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.71M 10-Q · filed 2023-05-11 | $2.28M derived: sum of 2 quarters · filed 2023-05-11 | $2.06M derived: sum of 3 quarters · filed 2023-05-11 | $3.02M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $566.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $345.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.30M derived: sum of 3 quarters · filed 2023-03-16 | $975.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | -$221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $738.00K derived: sum of 2 quarters · filed 2022-11-10 | $409.00K 10-Q · filed 2022-11-10 | $905.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $959.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $630.00K 10-Q · filed 2022-08-11 | $1.13M derived: sum of 3 quarters · filed 2022-08-11 | $987.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$329.00K 10-Q · filed 2022-05-12 | $167.00K derived: sum of 2 quarters · filed 2022-05-12 | $28.00K derived: sum of 3 quarters · filed 2022-05-12 | -$950.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $496.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $357.00K derived: sum of 2 quarters · filed 2022-03-17 | -$621.00K derived: sum of 3 quarters · filed 2022-03-17 | $555.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | -$139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | -$1.12M derived: sum of 2 quarters · filed 2021-11-01 | $59.00K 10-Q · filed 2021-11-01 | -$247.00K derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | -$978.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $198.00K 10-Q · filed 2021-08-05 | -$108.00K derived: sum of 3 quarters · filed 2021-08-05 | $564.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $1.18M 10-Q · filed 2021-05-03 | $870.00K derived: sum of 2 quarters · filed 2021-05-03 | $1.54M derived: sum of 3 quarters · filed 2021-05-03 | $1.72M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | -$306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $366.00K derived: sum of 2 quarters · filed 2021-03-16 | $548.00K derived: sum of 3 quarters · filed 2021-03-16 | $246.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $672.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $854.00K derived: sum of 2 quarters · filed 2020-11-10 | $552.00K 10-Q · filed 2020-11-10 | $926.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$120.00K 10-Q · filed 2020-08-06 | $254.00K derived: sum of 3 quarters · filed 2020-08-06 | |
| 2019-03-31 | -$302.00K 10-Q · filed 2020-05-12 | $72.00K derived: sum of 2 quarters · filed 2020-05-12 | ||
| 2018-12-31 | $374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $234.00K 10-K · filed 2020-03-30 | ||
| 2018-09-30 | -$140.00K 10-Q · filed 2019-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |